enVVeno Medical

En V Veno Medical

Medical Devices, 70 Doppler, Irvine, California, 92618, United States, 11-50 Employees

hancockjaffe.com

  • facebook
  • LinkedIn

phone no Phone Number: 19*********

Who is ENVVENO MEDICAL

enVVeno Medical (NASDAQ:NVNO) is an Irvine, California-based, late clinical-stage medical device company focused on the advancement of innovative bioprosthetic (tissue-based) solutions to...

Read More

map

industries-icon Industry: Medical Devices

SIC SIC Code: 3841 | NAICS Code: 339112 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ENVVENO MEDICAL

enVVeno Medical Org Chart and Mapping

Employees

Melanie Beltran

Research and Development Engineer

Marc Glickman

Chief Medical Officer, Sr Vice President

Hamed Alavi

Chief Technology Officer, Senior Vice President

Luong Nguyen

Sr Qa/Tech. R&D Engineer at Envveno

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding EnVVeno Medical

Answer: enVVeno Medical's headquarters are located at 70 Doppler, Irvine, California, 92618, United States

Answer: enVVeno Medical's phone number is 19*********

Answer: enVVeno Medical's official website is https://hancockjaffe.com

Answer: enVVeno Medical's revenue is $5 Million to $10 Million

Answer: enVVeno Medical's SIC: 3841

Answer: enVVeno Medical's NAICS: 339112

Answer: enVVeno Medical has 11-50 employees

Answer: enVVeno Medical is in Medical Devices

Answer: enVVeno Medical contact info: Phone number: 19********* Website: https://hancockjaffe.com

Answer: enVVeno Medical (NASDAQ:NVNO) is an Irvine, California-based, late clinical-stage medical device company focused on the advancement of innovative bioprosthetic (tissue-based) solutions to improve the standard of care in the treatment of venous disease. The Companys lead product, the VenoValve, is a first-in-class implant being developed for the treatment of deep venous Chronic Venous Insufficiency (CVI). In healthy patients, valves inside the veins of the leg assist in propelling blood up the leg, and back to the heart and lungs. Affecting approximately 2.4 million people in the United States, CVI occurs when valves inside of the veins of the leg become damaged, resulting in the backwards flow of blood (reflux), blood pooling in the lower leg, increased pressure in the veins of the leg (venous hypertension) and in severe cases, venous ulcers that are difficult to heal and become chronic. Implanted into the femoral vein, the VenoValve is designed to act as a one-way valve, to help restore proper blood flow in the leg. The VenoValve is currently being evaluated in the SAVVE pivotal study.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access